Democratic debate recap: Health insurance and drug prices get the spotlight
The last Democratic debate before the Iowa caucuses focused more on foreign policy than healthcare.
Regulatory
Appeals court considers HHS’ TV drug price disclosure rule
The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
Dive into the FDA ban on flavored e-cigarettes
Beginning Feb. 1, the e-cigarette industry will look much different.
Questions linger after Hahn takes over as FDA commissioner
Some Senators who questioned Hahn during his confirmation hearing expressed concern about his lack of regulatory and public policy experience.
A wrap-up of the biggest health policy news of 2019
To close out a busy year, MM&M rounded up the biggest health policy developments of 2019.
Stephen Hahn confirmed as FDA commissioner
The Senate confirmed Hahn for the role Thursday.
Healthcare spending grows to $3.6 trillion in 2018
A look at the new heights healthcare spending reached last year.
Infographic: What could you buy with the $20.5 trillion Elizabeth Warren’s health plan calls for in new federal spending?
That number got many of us at MM&M thinking: What else can be bought with $20,500,000,000,000?
Open enrollment on pace amid ACA uncertainty
The healthcare law is facing court challenges, but enrollment is chugging on.
Policy Outlook 2020: Expect loads of talk, little action around biggest healthcare issues
A presidential election in 2020 means candidates and surrogates will be talking about healthcare, but the chances of meaningful change are slim.
Want to read more?
Please login or register first to view this content.
